Study the Relationship between Severity of Post-Vaccination with Infection of COVID-19 and Vaccination
Alaa Hamza Jaber Al-Jelehawy, Ali Redha Abdulamer Sherali
Microbiology Research Journal International · pp. 9–13 · Published 30 Dec 2023
10.9734/mrji/2023/v33i11-121412Abstract
Background: The pandemic illness of coronavirus 2019 is caused by (SARS-CoV-2), it was started from China in December 2019. It speedily disseminate in the world and became a general threat. More than 5 million persons have died in the world. Aim of the Study: For assessments the relationship between vaccination and severity of post-vaccination with COVID-19 infection. Methods: This study had been conducted on (120) qRT- PCR confirmed infected individuals by COVID-19 (55 females and 65 males) ages ranging in 18-80 years from September 2023 to December 2023. Results: In the current study found from 120 patients positive with COVID-19, 65(54.16%) male and were female 55(45.86%), the difference was statistically not significant. The current study showed the age groups (20-30) years and (41-50) were the most affected (21.6%) and (18.6%) respectively. Present result showed that 28 (23.3%) had mild diseases, 40 (33.3%) had moderate diseases, 36 (30%) had severe diseases and16 (13.3) were admitted to critical care, that was statistically significant. In this study, 18\120 (15%) of patients who had received the vaccine against COVID-19 virus where 4\18 (22.22.%) received Pfizer and 14\18 (77.77%) Astra Zeneca. Conclusion: These urvey exhibited that there was no important difference between females and males.
Cited by 0
No indexed citations yet.
Related research
- Seroprevalence of Hepatitis B and Listeriosis Co-Infection among Patients Attending Sickbay Hospital, Ahmadu Bello University, Zaria, Kaduna, Nigeria — shares topic coverage
- Serological and Immunohistochemical Prevalence of Human Cytomegalovirus Co-infection among Hepatitis C Virus Patients Admitted to Kafer El Shiekh Liver and Heart Institute, Egypt — shares topic coverage
- Prevalence and Risk Factors of Hepatitis B among HIV Positive Patients Receiving Haart at Federal Medical Centre Makurdi, Benue State: A Cohort Study — shares topic coverage
- Undiagnosed Chronic Hepatitis B Infection and HIV Type 1 Drug Resistance Profile in AIDS Patients Receiving Tenofovir-containing Antiretroviral Regimens: Considerations for Monitoring Resistant HIV Variants during Treatment — shares topic coverage
- Co-Infection of Hepatitis B Virus and Hepatitis Delta Virus in Yaounde-Cameroon — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.